ENTITY
Mega Lifesciences

Mega Lifesciences (MEGA TB)

83
Analysis
Health Care • Thailand
Mega Lifesciences is a leading international pharmaceutical and nutraceutical company that manufactures, markets, sells, and distributes quality pharmaceutical products, medicinal supplements, and personal health products. The company also operates through its branded products segment, Mega We Care, and a distribution platform, Maxxcare, for third-party products. It is headquartered in Bangkok, Thailand, and was founded in 1982.
more
•19 Feb 2025 01:29•Broker

Special Report: Pressure Makes Diamonds - February 17, 2025

The Thai stock market has declined sharply by 14.8% from its 2024 peak, making Thai equities attractive from a valuation perspective.

Logo
271 Views
Share
bullish•Hyphens Pharma
•04 Sep 2026 15:00•Broker

Hyphens Pharma - 1H26 Earnings Update - Record Margins but Catalysts Still Key for Rerating

We maintain NEUTRAL on Hyphens with a revised target price of S$0.40/share, based on 10.5x FY26E P/E and at a slight discount to the peer average.

•28 Oct 2022 08:37•Broker

Changing Landscape for Global Plays - Shifting the Allocation of Global Plays Toward Asia

The global economy is less synchronized than in the past, meaning that a global plays strategy should be more area focused to enhance the growth...

Logo
316 Views
Share
•05 Aug 2022 07:35•Broker

Big Cap Tactical Picks - August 4, 2022

Yesterday, our Big Cap portfolio generated a return of +0.33% vs. the SET Index’s return of +0.35%. The share prices of stocks under the reopening...

Logo
269 Views
Share
•04 Aug 2022 08:12•Broker

Monthly Report - August 2022

We expect the SET Index to move up, with the support at 1,555/1,530 points and the resistance at 1,600/1,616 points, on the back of foreign...

Logo
357 Views
Share
x